Diindolylmethanes are present in not only natural pro-
ducts such as malassezin4 but also important precursors
for other naturally occurring heterocycles such as indolo-
carbazoles 2 and 3aꢀ3f5 shown in Figure 1.6 Malassezin,
ICZ, and FICZ are potent agonists of aryl hydrocarbon
receptor (AhR), which is best known for mediating the
toxicity of dioxin and related environmental toxins.7 Re-
cent studies showed that AhR also played a critical role in
immune cell differentiation,8 promoting intestinal immune
function,9 and the development of prostate.10 It has been
demonstrated that selective AhR modulators inhibit pros-
tate tumor metastasis11 and have antiasthmatic effects12 in
animal models. Indolo[3,2-b]carbazoles are also an impor-
tant class of organic electroluminescent compounds.6,13
Rearrangement of the symmetrical 3,30-diindolyl-
methanes to 2,3-diindolylmethanes could be realized using
iodine as the catalyst.14 Low yields, however, were ob-
served when substituted indoles were employed as the
substrates. Synthesis of nonsymmetric 2,3-diindolyl-
methanes requires the joining of two different indoles in
multiple steps.15
A metal carbene intermediate was generated from an-
nulation of propargylic ether 4 and trapped previously by a
diene in a (4 þ 3) cycloaddition.3a We envisioned that this
metal carbene intermediate could also be trapped by other
nucleophiles. In the presence of another indole, diindolyl-
methanes could then be prepared conveniently. We first
examined the conditions that were employed previously
(entries 1 and 2, Table 1). Wewere pleased tofind that both
Pt- and Rh-complexes promoted the formation of 2,30-
diindolylmethane product 6a, though the former provided
a higher yield. A slightly lower yield was obtained with a
lower catalyst loading (entry 3). The electron-poor phos-
phine ligand was proven to becriticalin the previous indole
annulation/(4 þ 3) cycloaddition cascade. In the case of
indole annulation/arylation to form diindolylmethanes,
using PtCl2 alone as the catalyst appeared to be sufficient
(entry 4). The yield again became slightly lower if the
amount of catalyst was lowered to 5 mol % (entry 5).
Other metal complexes did not produce any desired pro-
duct (entries 6ꢀ10).
Table 1. Screening of Catalysts and Conditionsa
entry
conditions
yield (%)
1
2
PtCl2 (10 mol %), P(C6F5)3 (20 mol %)
[Rh(CO)2Cl]2 (10 mol %), P[OCH(CF3)2]3
(20 mol %)
84
56
3
PtCl2 (5 mol %), P(C6F5)3 (10 mol %)
PtCl2 (10 mol %)
77
83b
76
0
4
5
PtCl2 (5 mol %)
6
AgBF4 (10 mol %)
7
AgOTf (10 mol %)
0
8
CuOTf (10 mol %)
0
9
AgOTf (10 mol %), P(C6F5)3 (20 mol %)
CuOTf (10 mol %), P(C6F5)3 (20 mol %)
0
10
0
a Unless noted otherwise, the yield of 6a was determined by 1H NMR
of crude product. b Isolated yield.
The scope of different indoles was examined for this
tandem indole annulation/arylation cascade using pro-
pargylic ether 4 as the starting material (Table 2).
Figure 1. Diindolylmethanes and indolo[3,2-b]carbazoles.
(6) (a) Knolker, H. J.; Reddy, K. R. Chem. Rev. 2002, 102, 4303. (b)
Schmidt, A. W.; Reddy, K. R.; Knoelker, H.-J. Chem. Rev. 2012, 112,
3193.
(7) Denison, M. S.; Soshilov, A. A.; He, G.; Degroot, D. E.; Zhao, B.
Toxicol. Sci. 2011, 124, 1.
(11) Fritz, W. A.; Lin, T.-M.; Safe, S.; Moore, R. W.; Peterson, R. E.
Biochem. Pharmacol. 2009, 77, 1151.
(12) Jeong, K.-T.; Hwang, S.-J.; Oh, G.-S.; Park, J.-H. Int. Immuno-
pharmacol. 2012, 13, 377.
(8) (a) Quintana, F. J.; Basso, A. S.; Iglesias, A. H.; Korn, T.; Farez,
M. F.; Bettelli, E.; Caccamo, M.; Oukka, M.; Weiner, H. L. Nature 2008,
453, 65. (b) Stevens, E. A.; Mezrich, J. D.; Bradfield, C. A. Immunology
2009, 127, 299.
(13) (a) Gu, R.; Robeyns, K.; Van Meervelt, L.; Toppet, S.; Dehaen,
W. Org. Biomol. Chem. 2008, 6, 2484. (b) Boudreault, P. L. T.; Wakim,
S.; Tang, M. L.; Tao, Y.; Bao, Z. A.; Leclerc, M. J. Mater. Chem. 2009,
19, 2921.
(9) (a) Li, Y.; Innocentin, S.; Withers, D. R.; Roberts, N. A.;
Gallagher, A. R.; Grigorieva, E. F.; Wilhelm, C.; Veldhoen, M. Cell
2011, 147, 629. (b) Kiss, E. A.; Vonarbourg, C.; Kopfmann, S.; Hobeika,
E.; Finke, D.; Esser, C.; Diefenbach, A. Science 2011, 334, 1561.
(10) Mehta, V.; Vezina, C. M. Differentiation 2011, 82, 211.
(14) (a) Gu, R.; Hameurlaine, A.; Dehaen, W. Synlett 2006, 1535. (b)
Gu, R.; Hameurlaine, A.; Dehaen, W. J. Org. Chem. 2007, 72, 7207.
(15) (a) Tholander, J.; Bergman, J. Tetrahedron Lett. 1998, 39, 1619.
(b) Tholander, J.; Bergman, J. Tetrahedron 1999, 55, 6243. (c) Wahlstrom,
N.; Stensland, B.; Bergman, J. Synthesis 2004, 1187.
B
Org. Lett., Vol. XX, No. XX, XXXX